Oopsie: https://archive.ph/3OSD8
Future COVID-19 vaccinations from Pfizer will be using the commercially-approved Comirnaty, not the emergency authorized vaccine we currently get.
And guess what? Comirnaty doesn't enjoy the same immunity from lawsuits that the emergency authorized drug did.
So now Pfizer is less gung-ho about jabbing everybody...
EVERY single pharmaceutical that is tested for years at great expense comes with a boatload of negatives. And they expect us to believe that a “vaccine” created at “warp speed” with no liability to the manufacturer is totally and completely safe. NO way. NO how. NO chance. A big lie.
Why can’t someone get their point across without using foul language? He loses credibility in my book.
Put a language warning on this. He is disgusting.
Did you guys get your free government Covid-19 test kits? I got mine. They are nice to have but did anyone else notice that they are made in China?
bkmk
What’s with the 666 symbol on his coffee table?
Could only handle a few minutes. But if he is vaxxed, as has already been said - ‘May the odds be ever in (his) favor’.
Killed is one thing/ How many people are now partly disabled by their vaxx? With half their normal lung capacity, clots and other problems. Shaking all over. Getting Parkinson’s like symptoms. All from a dumb vaxx.
Have you seen this??
Bad News from Hong Kong - by Igor Chudov (substack.com)
Bad News from Hong Kong
Cases and DEATHS exploding despite “Zero Covid” and Vaccination
igorchudov.substack.com
https://igorchudov.substack.com/p/bad-news-from-hong-kong?s=r
Hong Kong.....with jab rates close to US and Israel...
h/t sweetiepizer
UNITED STATES
OMB APPROVAL
OMB Number: 3235-0080
Expires: March 31, 2018
Estimated average burden
hours per response: 1.7
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-03619
Issuer: PFIZER INC
Exchange: NEW YORK STOCK EXCHANGE LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: 235 East 42nd Street
New York NEW YORK 10017
Telephone number: (212) 733-2323
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
0.250% Notes due 2022
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
17 CFR 240.12d2-2(a)(1)
17 CFR 240.12d2-2(a)(2)
17 CFR 240.12d2-2(a)(3)
17 CFR 240.12d2-2(a)(4)
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2022-03-07 By Lauren Frawley Analyst, Market Watch and Proxy Compliance
Date Name Title
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.